Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Apr 29:9:532.
doi: 10.3332/ecancer.2015.532. eCollection 2015.

Screening of cervical cancer in Catalonia 2006-2012

Affiliations

Screening of cervical cancer in Catalonia 2006-2012

Silvia de Sanjosé et al. Ecancermedicalscience. .

Abstract

The early detection of intraepithelial lesions of the cervix, through the periodic examination of cervical cells, has been fundamental for the prevention of invasive cervical cancer and its related mortality. In this report, we summarise the cervical cancer screening activities carried out in Catalonia, Spain, within the National Health System during 2008-2011. The study population covers over two million women resident in the area. The evaluation includes 758,690 cervical cytologies performed on a total of 595,868 women. The three-year coverage of cervical cytology among women aged between 25 and 65 years was 40.8%. About 50% of first screened women with negative results had not returned to the second screening round. The introduction of high-risk human papillomavirus DNA (HPV) detection, as a primary screening cotest with cytology among women over age 40 with a poor screening history, significantly improved the detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+), being far superior to cytology alone. Cotesting did not improve the detection of CIN2+. The use of the HPV test for the triage of atypical squamous cell undetermined significance (ASC-US) improved the selection of women at high risk of CIN2+. Sampling (both cytology and HPV test) was largely performed by midwives (66.7%), followed by obstetricians (23.8%) and nurses (7%). Over half of the centres (54.8%) had full use of online medical records. During the study period, educational activities for professionals and for women were carried out periodically. The organisation of screening as a population activity in which women are actively called to the screening visit and the introduction of HPV testing as a primary screening tool are strongly recommended to ensure the maximum population impact in the reduction of the cervical cancer burden.

Keywords: HPV; cervical cancer; coverage; screening.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Distribution of abnormal cytology for the period 2008–11 by age group in Catalonia.

References

    1. Bosch FX, et al. Comprehensive control of human papillomavirus infections and related diseases. Vaccine. 2012;30:S5. - PubMed
    1. Kitchener HC, Castle PE, Cox JT. Achievements and limitations of cervical cytology screening. Vaccine. 2006;24:S3/63–70. doi: 10.1016/j.vaccine.2006.05.113. - DOI - PubMed
    1. Bruni L, et al. Human papillomavirus and related diseases in the world. Summary report. [24.03.2015].
    1. Puig-Tintoré LM, Torné A, Alonso I. Current techniques in screening for cervical cancer in Spain: updated recommendations. Gynecol Oncol. 2008;110(3 Suppl 2):S8–S10. doi: 10.1016/j.ygyno.2008.05.013. - DOI - PubMed
    1. Puig-Tintoré LM, et al. Coverage and factors associated with cervical cancer screening: results from the AFRODITA study: a population-based survey in Spain. J Low Genit Tract Dis. 2008;12(2):82–89. doi: 10.1097/LGT.0b013e3181599c16. - DOI - PubMed